Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-27T11:28:13.853Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmaceutical influences – Nurse prescribers: eyes wide open

Published online by Cambridge University Press:  22 June 2006

Jill Davies  and
Steve Hemingway
Jill Davies
Affiliation:
Programme Leader Extended/Supplementary Prescribing Course, The University of Sheffield
Steve Hemingway
Affiliation:
Lecturer in Mental Health Nursing, The University of Sheffield
Get access Rights & Permissions [Opens in a new window]

Extract

Summary

The role of the Pharmaceutical Industry within healthcare has been a debate amongst our medical colleagues for the past decade. However, with the growing number of nurses who are now qualified to prescribe, this controversial aspect of professional practice is becoming an area of interest to nurses. This article reviews some of the literature on prescribing and the pharmaceutical Industry, in an attempt to raise nurses awareness. Nurses have skills that are central to their education of assessment and evaluation. It argues that nurses are well placed to utilise these skills to identify the influences of the Pharmaceutical Industry. The role of the Pharmaceutical Industry in professional development is debated, suggesting that nurses have the skills to analyse the potential impact of this form of education. Concepts of Ethics are discussed in relation to prescribing, patient care and professional education and practice.

Type
Focus On
Information
Nurse Prescriber , Volume 1 , Issue 12 , December 2004 , pp. 1 - 4 , e224
Copyright
© 2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kessenich C, The Garden of Good and Evil: Pharmaceutical Companies and Prescriptive Practices of PNPs. J Paediat Health 2000 November/December.Google Scholar
Hemingway S, Mental health nursing and the pharmaceutical industry. Ment Health Practice 2003; 7 (2): 22–23Google Scholar
Stokamer C, Pharmaceutical gift giving: analysis of an ethical dilemma. J Nurs Admin 2003; 33 (1): 48–51Google Scholar
While A, Biggs K. Benefits and challenges of nurse prescribing. J Advan Nurs 2004; 45 (6): 559–567.Google Scholar
National Prescribing Centre. Signposts for prescribing nurses-general principles of good prescribing; 1999.
Shaughnessy A, Slawson D. Pharmaceutical representatives. Editorial. Br Med J 1996; 312: 1494 (15th June).Google Scholar
Brookes N, Otway C, Rashid C, Kilty E, Maggs C. The patients' view: the benefits and limitations of nurse prescribing. Br J Commun Nurs 2001; 6: 342–348.Google Scholar
Latter S, Courtenay M. Effectiveness of nurse prescribing: a review of the literature. J Clin Nurs 2004; 13 (1): 26–32.Google Scholar
Leifer D. Nurses Vulnerable to Inducements, Claims Unison Officer: Warning over drugs courses. Nurs Stand 1997; 11 (46): 9.Google Scholar
Hall J, Cantrill J, Noyce P. Professional Issues. The information sources used by community nurse prescribers. Br J Nurs 2003; 12 (13): 810–818.Google Scholar
Moyniham R, Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement. Br Med J 2003; 326 31st May.Google Scholar
Lipley N., Rich pickings. Nurs Stand 2000; 14 (36): 12–13.Google Scholar
Nursing and Midwifery Council. Code of professional conduct. London: NMC; 2002.
Wager E. How to dance with the porcupines: rules and guidelines on doctors' relations with drug companies; BMJ 2003.326:1196–1198Google Scholar
Beauchamp TL, Childress JF. Principles of bio-medical ethics. 3rd ed. New York: Oxford University Press; 1989.